Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2015
∙
WHO, SAGE
Pertussis Vaccines: WHO position paper
2015
∙
JCVI
Protocols for vaccine manufacturer engagement with JCVI sub-committees
2015
∙
NACI
Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23)
2015
∙
WHO
Reducing pain at the time of vaccination
2015
∙
NACI
Statement on Seasonal Influenza Vaccine for 2015-2016
2015
∙
WHO
Summary of WHO Position Papers - Recommendations for Interrupted or Delayed Routine Immunization
2015
∙
WHO
Summary of WHO Position Papers – Immunization of Health Care Workers
2015
∙
NACI
Update on Quadrivalent Meningococcal Vaccines available in Canada
2015
∙
NACI
Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule
2015
∙
SAGE
What is the effectiveness of inactivated Vero cell-derived JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register